FDA approves new weight loss drug Zepbound

FDA approves new weight loss drug Zepbound – CBS News


Watch CBS News



The Food and Drug Administration has approved the diabetes drug Mounjaro, which will be marketed as a weight loss drug under the name Zepbound.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


Leave a Reply

Your email address will not be published. Required fields are marked *